Sue Barrowcliffe BSc, Non Executive Director

Sue is an independent drug development and regulatory affairs consultant. She has over 20 years experience in global drug development and regulatory affairs obtained in both large and small companies. Sue spent 5 years as Vice President Worldwide Product Registration at SmithKline Beecham during which time she led the marketing approval of 4 new chemical entities and multiple line extensions across a number of therapeutic areas including oncology, cardiovascular, CNS and metabolic disorders. Following this she spent 4 years at British Biotech where she led the development team in progressing a first in class antibiotic into Phase I trials and establishing Phase I and II studies for novel oncology agents. Most recently Sue spent 2 years at Chiron Biopharmaceuticals, where she led the European Regulatory Affairs team and was responsible for directing 2 successful pan- European new product registrations.

Sue has been involved with Pharminox since the beginning of 2004, initially as CEO and since October 2004 as a non-executive director. During her term as CEO Sue negotiated the option agreement with CRT for Phortress. Sue has a First Class Honours Degree in Biochemistry from Sheffield University.